Normalized adjusted EBITDA(1) remained relatively stable at $59.4 million in the quarter, compared to $60.4 million in Q4-23.System sales(2) for the quarter improved by 2% or $30.3 million to reach $1 ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...